WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:WELL - CA94947L1022 - Common Stock
3.96 CAD
-0.03 (-0.75%)
Overall WELL gets a fundamental rating of 3 out of 10. We evaluated WELL against 14 industry peers in the Health Care Providers & Services industry. WELL may be in some trouble as it scores bad on both profitability and health. WELL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year WELL has reported negative net income.
WELL had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: WELL reported negative net income in multiple years.
Of the past 5 years WELL 4 years had a positive operating cash flow.
1.2 Ratios
WELL has a Return On Assets (-2.14%) which is comparable to the rest of the industry.
The Return On Equity of WELL (-5.12%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin (39.97%) which is comparable to the rest of the industry.
WELL's Gross Margin has improved in the last couple of years.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
WELL has more shares outstanding than it did 5 years ago.
WELL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.07, we must say that WELL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.07, WELL perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
A Debt/Equity ratio of 0.67 indicates that WELL is somewhat dependend on debt financing.
WELL has a better Debt to Equity ratio (0.67) than 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.07 |
ROIC/WACCN/A
WACC8.13%
2.3 Liquidity
A Current Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
The Current ratio of WELL (0.92) is better than 78.57% of its industry peers.
A Quick Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.92, WELL is doing good in the industry, outperforming 78.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for WELL have decreased strongly by -200.00% in the last year.
The Revenue has grown by 26.20% in the past year. This is a very strong growth!
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
3.2 Future
Based on estimates for the next years, WELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.72% on average per year.
Based on estimates for the next years, WELL will show a quite strong growth in Revenue. The Revenue will grow by 15.80% on average per year.
EPS Next Y181.06%
EPS Next 2Y66.97%
EPS Next 3Y42.44%
EPS Next 5Y19.72%
Revenue Next Year41.58%
Revenue Next 2Y25.55%
Revenue Next 3Y18.77%
Revenue Next 5Y15.8%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 9.47, the valuation of WELL can be described as reasonable.
Based on the Price/Forward Earnings ratio, WELL is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.69. WELL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WELL is valued a bit cheaper than 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.03 |
4.3 Compensation for Growth
WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WELL's earnings are expected to grow with 42.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.97%
EPS Next 3Y42.44%
5. Dividend
5.1 Amount
WELL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (12/5/2025, 7:00:00 PM)
3.96
-0.03 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.3%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts81
Price Target7.8 (96.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.08%
Min EPS beat(2)-41.18%
Max EPS beat(2)-32.99%
EPS beat(4)0
Avg EPS beat(4)-244.03%
Min EPS beat(4)-696.08%
Max EPS beat(4)-32.99%
EPS beat(8)2
Avg EPS beat(8)1902.08%
EPS beat(12)3
Avg EPS beat(12)1068.91%
EPS beat(16)3
Avg EPS beat(16)736.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.18%
PT rev (1m)-0.23%
PT rev (3m)-0.23%
EPS NQ rev (1m)5.61%
EPS NQ rev (3m)36.97%
EPS NY rev (1m)30.98%
EPS NY rev (3m)1376.18%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.47 | ||
| P/S | 0.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.03 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.42
Fwd EY10.56%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.76
BVpS3.33
TBVpS-2.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.23 | ||
| Cap/Depr | 27.43% | ||
| Cap/Sales | 2.1% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.07 |
F-Score1
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y181.06%
EPS Next 2Y66.97%
EPS Next 3Y42.44%
EPS Next 5Y19.72%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year41.58%
Revenue Next 2Y25.55%
Revenue Next 3Y18.77%
Revenue Next 5Y15.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.58%
EBIT Next 3Y64.26%
EBIT Next 5Y47.63%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES COR / WELL.CA FAQ
What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to WELL.CA.
What is the valuation status of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.
What is the profitability of WELL stock?
WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 2 / 10.
How financially healthy is WELL HEALTH TECHNOLOGIES COR?
The financial health rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 2 / 10.